FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890185108> ?p ?o ?g. }

• W2890185108 endingPage "225" @default.
• W2890185108 startingPage "217" @default.
• W2890185108 abstract "In this work, we used the small angle X-ray scattering (SAXS) method for controlled preparation of in situ forming sustained-release carriers for the antitumor drug bufalin (BUF), which has very poor solubility and a considerable cardiotoxicity in a non-encapsulated state. To that aim, we exploited the pseudo-ternary phase diagram of an oil(O)/surfactant(S)/water(W) system containing medium chain capric/caprylic triglycerides (MCT) and a co-surfactant blend of Macrogol (15)-hydroxystearate (Solutol HS 15) and sorbitan monooleate (Span 80). Two compositions with different oil contents (sample B and C) were selected from the microemulsion region of the phase diagram in order to study the effect of the aqueous environment on their structural behavior. A phase transition from a microemulsion (ME) to a liquid crystalline phase (LC) was established by SAXS upon progressive dilution. The drug bufalin (BUF) was encapsulated in the microemulsions with low viscosity, whereas the release of the drug occurred from the in situ generated lamellar liquid crystalline structures. The formulations were characterized by SAXS, dynamic light scattering (DLS), cryogenic transmission electron microscopy (Cryo-TEM), rheology, drug loading and encapsulation efficiency, and in vitro release profiles. A correlation was suggested between the structures of the in situ phase-transition formed LCME formulations, the differences in their viscosities and drug release profiles. The performed cytotoxicity, cell apoptosis and pharmacokinetic experiments showed an enhanced bioavailability of BUF after encapsulation. These results suggest potential clinical applications for the obtained safe in situ phase-transition sustained-release formulations of BUF." @default.
• W2890185108 created "2018-09-27" @default.
• W2890185108 creator A5016805696 @default.
• W2890185108 creator A5028025452 @default.
• W2890185108 creator A5031315906 @default.
• W2890185108 creator A5038629448 @default.
• W2890185108 creator A5058759123 @default.
• W2890185108 creator A5074800265 @default.
• W2890185108 creator A5081478101 @default.
• W2890185108 creator A5089645804 @default.
• W2890185108 date "2019-01-01" @default.
• W2890185108 modified "2023-10-18" @default.
• W2890185108 title "In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin" @default.
• W2890185108 cites W1776212066 @default.
• W2890185108 cites W1963734597 @default.
• W2890185108 cites W1974675726 @default.
• W2890185108 cites W1996424650 @default.
• W2890185108 cites W2016081626 @default.
• W2890185108 cites W2017981926 @default.
• W2890185108 cites W2023616087 @default.
• W2890185108 cites W2023677664 @default.
• W2890185108 cites W2024313626 @default.
• W2890185108 cites W2035152323 @default.
• W2890185108 cites W2037608127 @default.
• W2890185108 cites W2041127822 @default.
• W2890185108 cites W2045241717 @default.
• W2890185108 cites W2048719138 @default.
• W2890185108 cites W2048959789 @default.
• W2890185108 cites W2051836971 @default.
• W2890185108 cites W2062863981 @default.
• W2890185108 cites W2082176091 @default.
• W2890185108 cites W2083718919 @default.
• W2890185108 cites W2084002046 @default.
• W2890185108 cites W2089601479 @default.
• W2890185108 cites W2092253622 @default.
• W2890185108 cites W2099796991 @default.
• W2890185108 cites W2101773814 @default.
• W2890185108 cites W2121964995 @default.
• W2890185108 cites W2144417922 @default.
• W2890185108 cites W2144805364 @default.
• W2890185108 cites W2169555777 @default.
• W2890185108 cites W2258703481 @default.
• W2890185108 cites W2345230587 @default.
• W2890185108 cites W2467520120 @default.
• W2890185108 cites W2487150856 @default.
• W2890185108 cites W2519557472 @default.
• W2890185108 cites W2557562124 @default.
• W2890185108 cites W2576715449 @default.
• W2890185108 cites W2587701162 @default.
• W2890185108 cites W2593172296 @default.
• W2890185108 cites W2593912036 @default.
• W2890185108 cites W2606806481 @default.
• W2890185108 cites W2610617996 @default.
• W2890185108 cites W2619084621 @default.
• W2890185108 cites W4240821889 @default.
• W2890185108 doi "https://doi.org/10.1016/j.colsurfb.2018.09.023" @default.
• W2890185108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30296646" @default.
• W2890185108 hasPublicationYear "2019" @default.
• W2890185108 type Work @default.
• W2890185108 sameAs 2890185108 @default.
• W2890185108 citedByCount "28" @default.
• W2890185108 countsByYear W28901851082019 @default.
• W2890185108 countsByYear W28901851082020 @default.
• W2890185108 countsByYear W28901851082021 @default.
• W2890185108 countsByYear W28901851082022 @default.
• W2890185108 countsByYear W28901851082023 @default.
• W2890185108 crossrefType "journal-article" @default.
• W2890185108 hasAuthorship W2890185108A5016805696 @default.
• W2890185108 hasAuthorship W2890185108A5028025452 @default.
• W2890185108 hasAuthorship W2890185108A5031315906 @default.
• W2890185108 hasAuthorship W2890185108A5038629448 @default.
• W2890185108 hasAuthorship W2890185108A5058759123 @default.
• W2890185108 hasAuthorship W2890185108A5074800265 @default.
• W2890185108 hasAuthorship W2890185108A5081478101 @default.
• W2890185108 hasAuthorship W2890185108A5089645804 @default.
• W2890185108 hasBestOaLocation W28901851082 @default.
• W2890185108 hasConcept C11268172 @default.
• W2890185108 hasConcept C120665830 @default.
• W2890185108 hasConcept C121332964 @default.
• W2890185108 hasConcept C127413603 @default.
• W2890185108 hasConcept C131888329 @default.
• W2890185108 hasConcept C14631669 @default.
• W2890185108 hasConcept C155672457 @default.
• W2890185108 hasConcept C171250308 @default.
• W2890185108 hasConcept C178790620 @default.
• W2890185108 hasConcept C184651966 @default.
• W2890185108 hasConcept C185592680 @default.
• W2890185108 hasConcept C190119865 @default.
• W2890185108 hasConcept C191486275 @default.
• W2890185108 hasConcept C192562407 @default.
• W2890185108 hasConcept C42360764 @default.
• W2890185108 hasConcept C43617362 @default.
• W2890185108 hasConcept C55493867 @default.
• W2890185108 hasConcept C58226133 @default.
• W2890185108 hasConceptScore W2890185108C11268172 @default.
• W2890185108 hasConceptScore W2890185108C120665830 @default.
• W2890185108 hasConceptScore W2890185108C121332964 @default.
• W2890185108 hasConceptScore W2890185108C127413603 @default.

• next